Carnitine deficiency and hyperammonemia associated with valproic acid therapy*
References (15)
- et al.
Hyperammonemia with valproic acid therapy
J Pediatr
(1981) - et al.
Systemic carnitine deficiency simulating recurrent Reye syndrome
J Pediatr
(1980) - et al.
A kinetic determination of ammonia in plasma
Clin Chim Acta
(1974) - et al.
A method for the determination of carnitine in the picomol range
Clin Chim Acta
(1972) - et al.
Secondary hyperammonemia: A possible mechanism for valproate encephalopathy
Lancet
(1980) - et al.
Valproic acid therapy in childhood epilepsy
JAMA
(1980) - et al.
Pancreatitis associated with valproic acid therapy for epilepsy
Ann Neurol
(1980)
There are more references available in the full text version of this article.
Cited by (252)
Valproic Acid Overdose: Case Report and Literature Review
2022, Journal of Emergency MedicineThe Roles of Antidotes in Emergency Situations
2022, Emergency Medicine Clinics of North AmericaCitation Excerpt :During the process of mitochondrial β-oxidation, VPA depletes carnitine stores. Carnitine supplementation is well tolerated and may be beneficial in acute and chronic valproate exposure.100–104 Additionally, the supplementation of levocarnitine may be beneficial in high-risk patients.99
Effects of L-carnitine supplementation in patients with childhood-onset epilepsy prescribed valproate
2021, Epilepsy and BehaviorEASL Clinical Practice Guidelines: Drug-induced liver injury
2019, Journal of HepatologyEvaluation ofserum free carnitine/acylcarnitine levels and left ventricular systolic functions in children with idiopathic epilepsy receiving valproic acid
2018, Clinical Neurology and Neurosurgery
- *
Supported by a grant from the Ministry of Health and Welfare, Japan.
Copyright © 1982 Published by Mosby, Inc.